Juvenile Idiopathic Arthritis — Trials, FDA Actions & Pivotal Research

20 active Juvenile Idiopathic Arthritis trials currently recruiting in the US, sourced from ClinicalTrials.gov.

Synced daily from openFDA and ClinicalTrials.gov. Last sync: June 12, 2026.

Active Juvenile Idiopathic Arthritis trials

Currently recruiting US trials matching Juvenile Idiopathic Arthritis, sourced live from ClinicalTrials.gov. We’ll add per-event articles here as those trials post results or hit primary completion.

Validity and Reliability of the International Physical Fitness Questionnaire and the Self-Perceived Health-Related Physical Fitness Questionnaire in Children and Adolescents With JIA and FMF

for Juvenile Idiopathic Arthritis

Sponsor: Istanbul University - Cerrahpasa

Sex: All·Age: 10 - 18

Code: NCT07617558·Not Yet Recruiting

Sarcopenia and Juvenile Idiopathic Arthritis

for Juvenile Idiopathic Arthritis

Sponsor: CHU de Reims

Sex: All·Age: 15 - 40

Code: NCT07634354·Not Yet Recruiting

Tenosynovitis in Polyarticular and Oligoarticular Juvenile Idiopathic Arthritis

for Juvenile Idiopathic Arthritis

Sponsor: Assiut University

Sex: All·Age: Up to 16

Code: NCT07553910·Not Yet Recruiting

A Study on the Use of Canakinumab Among Familial Mediterranean Fever and Still's Disease Patients

for Familial Mediterranean Fever

Sponsor: Novartis Pharmaceuticals

Sex: All·Age: 1+

Code: NCT07517250·Recruiting

Apply to this trial

Methotrexate Alone vs Methotrexate + Etanercept for Minimal/Low Disease Activity in Juvenile Idiopathic Arthritis

for Juvenile Idiopathic Arthritis

Sponsor: University of Child Health Sciences and Children's Hospital, Lahore

Sex: All·Age: 2 - 16·Accepts healthy volunteers

Code: NCT07386587·Phase 3·Enrolling By Invitation

Regulatory Post-Marketing Surveillance in Hidradenitis Suppurativa, Pediatric Plaque Psoriasis and JIA Treated With Cosentyx®(Secukinumab) in Korea

for Hidradenitis Suppurativa

Sponsor: Novartis Pharmaceuticals

Sex: All·Age: 6 - 100

Code: NCT07243782·Recruiting

Apply to this trial

Pain in Juvenile Arthritis

for Juvenile Idiopathic Arthritis

1 location in St Louis

Sponsor: Washington University School of Medicine

Sex: All·Age: 9 - 17·Accepts healthy volunteers

Code: NCT07217782·Recruiting

Apply to this trial

Clinical Study of BCMA/CD70-targeted CAR-T Therapy for Refractory Pediatric Rheumatic Diseases

for Juvenile Dermatomyositis (JDM)

Sponsor: Chongqing Precision Biotech Co., Ltd

Sex: All·Age: 5+

Code: NCT07184450·Phase 1·Recruiting

Apply to this trial

Assessment of Composite Inflammatory Ratios in Juvenile Idiopathic Arthritis and Their Association With Disease Activity

for Juvenile Idiopathic Arthritis

Sponsor: Sohag University

Sex: All·Age: Up to 16·Accepts healthy volunteers

Code: NCT07083466·Not Yet Recruiting

Prospective Observational Study to Evaluate Secukinumab Treatment Effectiveness in Pediatric Patients With Active Juvenile Enthesitis-related or Psoriatic Arthritis

for Juvenile Idiopathic Arthritis

Sponsor: Novartis Pharmaceuticals

Sex: All·Age: 6 - 18

Code: NCT06431750·Not Yet Recruiting

Feasibility of a Diet Intervention for Juvenile Arthritis

for Arthritis, Juvenile

Sponsor: The Hospital for Sick Children

Sex: All·Age: 8 - 18

Code: NCT06474546·Recruiting

Apply to this trial

Dynamic Gait Index as a Functional Gait Assessment Measure in Children With JIA

for Juvenile Idiopathic Arthritis

Sponsor: Istanbul University - Cerrahpasa

Sex: All·Age: 8 - 16·Accepts healthy volunteers

Code: NCT06870045·Recruiting

Apply to this trial

Mesenchymal Stem Cells Infusion in Patients With Autoimmune Diseases

for Rheumatoid Arthritis

Sponsor: National Institute of Blood and Marrow Transplant (NIBMT), Pakistan

Sex: All·Age: 18 - 50

Code: NCT06888973·Phase 1, Phase 2·Enrolling By Invitation

Optimizing Treatment for Patients With Juvenile Idiopathic Arthritis in Sustained Remission: The MOVE-JIA Trial

for Juvenile Idiopathic Arthritis

Sponsor: Oslo University Hospital

Sex: All·Age: 2 - 17

Code: NCT06653634·Phase 4·Recruiting

Apply to this trial

M3-JIA: Making Mindfulness Matter for Children With JIA

for Juvenile Idiopathic Arthritis

Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

Sex: All·Age: 4 - 12

Code: NCT06376149·Recruiting

Apply to this trial

Analysis of Peripheral Blood Lymphocytes in Patients With Juvenile Idiopathic Arthritis With Respect to Disease Subtypes and Therapy

for Juvenile Idiopathic Arthritis

Sponsor: Sohag University

Sex: All·Age: 6 Months - 16·Accepts healthy volunteers

Code: NCT06413563·Not Yet Recruiting

Study to Measure Filgotinib in the Blood of Children and Teenagers With Arthritis Taking Filgotinib (SCALESIA)

for Juvenile Idiopathic Arthritis

Sponsor: Alfasigma S.p.A.

Sex: All·Age: 8 - 18

Code: NCT06222034·Phase 1·Recruiting

Apply to this trial

Imaging Based Uveitis Screening for Children With Juvenile Idiopathic Arthritis

for Uveitis, Anterior

Sponsor: Institute of Child Health

Sex: All·Age: 2 - 12

Code: NCT05984758·Not Yet Recruiting

Korea Xeljanz Post-marketing Surveillance for Juvenile Idiopathic Arthritis

for Psoriatic Arthritis, Juvenile

Sponsor: Pfizer

Sex: All·Age: 2 - 17

Code: NCT05754710·Recruiting

Apply to this trial

Virtual Self-Management Program for JIA

for Juvenile Idiopathic Arthritis

Sponsor: University of Calgary

Sex: All·Age: 12 - 17

Code: NCT06184100·Recruiting

Apply to this trial